President Donald Trump has announced the formation of a new panel of science advisers, the President's Council of Advisors on Science and Technology (PCAST), which consists of 13 members, predominantly from the technology sector.Notably, only one of these members is a university researcher, raising concerns about the panel's composition and its implications for science policy in the United States.
Sources:
scientificamerican.comnature.comAmong the prominent tech figures appointed to the panel are Mark Zuckerberg, CEO of Meta; Larry Ellison, executive chairman of Oracle; and Sergey Brin, co-founder of Google.The panel's members also include leaders from tech hardware companies, such as Jensen Huang of NVIDIA and Lisa Su of Advanced Micro Devices.Together, these executives possess a staggering combined wealth exceeding $900 billion.
Sources:
scientificamerican.comnature.comThe sole academic representative on the panel is John Martinis, a quantum physicist from the University of California, Santa Barbara.Martinis was part of the team that won the Nobel Prize in Physics last year for significant advancements in quantum phenomena.He expressed his honor at being selected for the committee, indicating a potential focus on cutting-edge science.
Source:
scientificamerican.comCritics have voiced their apprehension regarding the panel's lack of diversity in scientific expertise.Vaughan Cooper, an evolutionary biologist at the University of Pittsburgh, highlighted the absence of biologists and emphasized the panel's inadequate preparation for the rapidly evolving field of biotechnology."This leaves the country unbelievably ill prepared for an age of biotechnology," Cooper stated, reflecting widespread concern within the scientific community.
Sources:
scientificamerican.comnature.comThe current structure of PCAST marks a significant departure from previous administrations.During Trump's first term, PCAST consisted of 13 members, including a mix of academic scientists and industry leaders.In contrast, the Biden administration had a much larger council with 28 members, of whom 19 were academic researchers.Historically, PCAST has usually included at least ten academic members, which makes the current selection unusual.
Sources:
nature.comesa.orgThe panel is expected to provide science policy recommendations to the White House on various issues, including improving nutrition science and enhancing the scientific workforce.It will also review existing cross-agency programs, such as the Networking and Information Technology Research and Development initiative.However, most of the council's work is carried out by subcommittees, with reports primarily prepared by staff from the federally funded Science and Technology Policy Institute in Washington, DC.
Sources:
scientificamerican.comnature.comThe Trump administration has outlined its research and development priorities, emphasizing artificial intelligence and quantum information as key areas of focus.The administration aims to quadruple US commercial nuclear power by 2050, reflecting its commitment to advancing technologies in these sectors.The committee will be co-chaired by David Sacks, an AI advocate, and Michael Kratsios, the director of the White House Office of Science and Technology Policy.
Source:
nature.comIn a recent statement on social media, Kratsios remarked that PCAST "unites America's brightest minds to advise the President on the most pressing national issues in science and technology," highlighting the council's mission to address the challenges and opportunities posed by emerging technologies.
Source:
scientificamerican.comAs Trump continues to shape the scientific landscape through his appointments, the long-term impact of this predominantly tech-focused council on the future of science policy remains to be seen.With the possibility of adding up to 11 more members in the future, there remains a chance for increased academic representation on the panel, which could help balance the technological emphasis.
Sources:
nature.comesa.orgThe White House has not yet commented on the criticisms regarding the panel’s composition, leaving many in the scientific community anxious about the direction of US science policy under this new advisory group.
